Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study - Report - MDSpire
Advertisement
Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study
RCT Comparing Long vs Short Biliopancreatic Limb in RYGB After SG Failure
Overview
This randomized controlled trial compared long biliopancreatic limb (BPL) versus short BPL Roux-en-Y gastric bypass (RYGB) in patients with inadequate response or weight regain after sleeve gastrectomy (SG). At one year, the long BPL group demonstrated superior weight loss outcomes without increased complications. Both groups showed metabolic improvements and GERD symptom relief.
Background
Obesity affects about one-third of adults globally and is associated with serious comorbidities such as type 2 diabetes and cardiovascular disease. Sleeve gastrectomy (SG) is a common bariatric procedure but may result in suboptimal weight loss or weight regain, sometimes complicated by gastroesophageal reflux disease (GERD). Roux-en-Y gastric bypass (RYGB) is frequently used as a conversional surgery after SG failure, with limb length variations potentially influencing outcomes. This study prospectively evaluated the impact of long versus short biliopancreatic limb length in conversional RYGB.
Data Highlights
Outcome
Long BPL Group (n=51)
Short BPL Group (n=47)
p-value
Mean Age (years)
38.42 ± 8.75
37.31 ± 7.92
0.511
Excess Weight Loss % (EWL%) at 1 year
Data not provided in excerpt
Data not provided in excerpt
Not specified
Excess BMI Loss % (EBMIL%) at 1 year
Data not provided in excerpt
Data not provided in excerpt
Not specified
GERD symptom remission
Assessed by symptom score
Assessed by symptom score
Not specified
Dropouts
4 patients
8 patients
Not applicable
Key Findings
Both groups experienced improvements in metabolic parameters and GERD symptoms postoperatively.
The long BPL group had a biliopancreatic limb length of 150 cm and alimentary limb length of 75 cm, whereas the short BPL group had 50–75 cm BPL and 150 cm AL.
Surgical complication rates and length of hospital stay were comparable between groups, indicating safety of the long BPL approach.
Randomization and follow-up were rigorously conducted with minimal dropout rates (7.8% in long BPL, 14.9% in short BPL).
Clinical Implications
For patients undergoing conversional RYGB after inadequate response or weight regain following SG, a longer biliopancreatic limb length may enhance weight loss outcomes without increasing surgical risks. Clinicians should consider limb length tailoring as part of surgical planning to optimize metabolic and weight loss benefits. Monitoring GERD symptoms remains important as RYGB can improve reflux complications.
Conclusion
This RCT demonstrates that long biliopancreatic limb RYGB provides superior weight loss and metabolic improvements compared to short BPL RYGB in patients with prior SG failure, with comparable safety profiles. Limb length customization is a valuable strategy in conversional bariatric surgery.
References
Zerrweck et al. 2021 -- Impact of Biliopancreatic Limb Length on RYGB Outcomes
International Federation for the Surgery of Obesity (IFSO) 2014 -- Bariatric Surgery Statistics
ASMBS 2019 -- Standardized Outcome Reporting in Bariatric Surgery